Journal
VASCULAR PHARMACOLOGY
Volume 71, Issue -, Pages 192-200Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.vph.2015.03.006
Keywords
Vascular smooth muscle cells; Cardiovascular rhodopsin; Transgenic mice; Optogenetics; Channelrhodopsin
Categories
Funding
- National Institutes of Health [R01-NS-073875]
Ask authors/readers for more resources
Cardiovascular diseases are the major challenge to modern medicine. Intervention to cardiovascular cells is crucial for treatment of the diseases. Here we report a novel intervention to vascular smooth muscle (VSM) cells by optogenetics. Channelrhodopsin in a tandem with YFP was selectively expressed in smooth muscle of transgenic mice in which YFP fluorescence was found in arterial walls of various tissues. In dissociated VSM cells from the mice blue light evoked inward currents, leading to depolarization and contraction. In isolated mesenteric arterial rings, optostimulation produced vasoconstriction that was reproducible, sustained, light intensity-dependent and comparable to popular vasoconstrictors. Blue light raised robustly coronary resistance without significant effects on heart rate and pulse pressure. Optostimulation produced renal vasoconstriction as well. The optical vasoconstriction had temporal resolutions less than 40 s in these organs. These results indicate that optical vasoconstriction can be effectively produced in various organs with channelrhodopsin expression in VSM cells. (C) 2015 Elsevier Inc All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available